Cargando…
EditR: A Method to Quantify Base Editing from Sanger Sequencing
CRISPR-Cas9-Cytidine deaminase fusion enzymes—termed “base editors”—allow targeted editing of genomic deoxycytidine to deoxythymidine (C:G→T:A) without the need for double-stranded break induction. Base editors represent a paradigm shift in gene editing technology due to their unprecedented efficien...
Autores principales: | Kluesner, Mitchell G., Nedveck, Derek A., Lahr, Walker S., Garbe, John R., Abrahante, Juan E., Webber, Beau R., Moriarity, Branden S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694769/ https://www.ncbi.nlm.nih.gov/pubmed/31021262 http://dx.doi.org/10.1089/crispr.2018.0014 |
Ejemplares similares
-
MultiEditR: The first tool for the detection and quantification of RNA editing from Sanger sequencing demonstrates comparable fidelity to RNA-seq
por: Kluesner, Mitchell G., et al.
Publicado: (2021) -
CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells
por: Kluesner, Mitchell G., et al.
Publicado: (2021) -
Highly multiplexed genome engineering using CRISPR/Cas9 gRNA arrays
por: Kurata, Morito, et al.
Publicado: (2018) -
Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease
por: Johnson, Matthew J., et al.
Publicado: (2018) -
SangeR: the high-throughput Sanger sequencing analysis pipeline
por: Schmid, Kai, et al.
Publicado: (2022)